Pallas Capital Advisors’s Stantec STN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$529K Sell
6,122
-300
-5% -$28.2K 0.02% 492
2025
Q4
$606K Sell
6,422
-289
-4% -$29.8K 0.02% 480
2025
Q3
$723K Sell
6,711
-187
-3% -$20.4K 0.03% 417
2025
Q2
$750K Hold
6,898
0.03% 392
2025
Q1
$571K Sell
6,898
-559
-7% -$44.7K 0.02% 428
2024
Q4
$585K Hold
7,457
0.03% 338
2024
Q3
$611K Hold
7,457
0.03% 314
2024
Q2
$644K Sell
7,457
-62
-0.8% -$5.05K 0.03% 271
2024
Q1
$624K Hold
7,519
0.03% 252
2023
Q4
$603K Sell
7,519
-200
-3% -$13.9K 0.03% 247
2023
Q3
$473K Buy
+7,719
New +$513K 0.03% 239

Other funds holding STN

Pallas Capital Advisors's STN Position: Q1 2026 in Review

Pallas Capital Advisors reduced its Stantec (STN) stake by 4.7% in Q1 2026, selling an estimated $28.2K and leaving 6,122 shares worth $529K. The position accounts for 0.02% of the portfolio, ranked #492.

Pallas Capital Advisors first reported a position in STN in Q3 2023 and has held it in 11 quarters since. The position peaked at $750K in Q2 2025. 308 funds tracked by Wall St. Rank hold STN as of Q1 2026.

  • Pallas Capital Advisors held 6,122 shares of Stantec worth $529K as of Q1 2026.
  • Pallas Capital Advisors sold 300 Stantec shares in Q1 2026, an estimated $28.2K.
  • Stantec made up 0.02% of Pallas Capital Advisors's portfolio in Q1 2026, its #492 holding.
  • Pallas Capital Advisors first reported a position in Stantec in Q3 2023 and has held it in 11 quarters since.
  • Pallas Capital Advisors's Stantec position peaked at $750K in Q2 2025.
  • 308 funds tracked by Wall St. Rank held Stantec as of Q1 2026.

Based on Pallas Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.